Health Condition 1: - Health Condition 2: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Trifarotene 0.005%: Trifarotene 0.005% cream, a pea size quantity should be taken and apply over entire face initially over 2 hrs , if no irritation 5 hrs and followed by overnight for
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: Patients attending SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE Dermatology OPD and diagnosed with Acne Vulgaris. Patients willing to take topical medication for Acne vulgaris. Patients providing voluntary informed and written consent for the explained treatment modality . Patient age 18 years and older. Patient of either sex with mild and moderate facial acne according to IGA score (Investigators global assessment ) score and GAGS ( Global Acne Grading System).
Exclusion criteria
Exclusion criteria: Severe form of acne Greater than one nodule on the face Presence of acne cysts, excessive beard, facial hair that could interfere with study assessments. Known or suspected allergies or sensitivities to the planned study drug. Intent to conceive during the study in women . Lactating mothers during the study Patients who have not given written consent for participation in study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of acneTimepoint: 4 weeks - reduction of comedones along with redness 8 weeks- reduction of comedones along with pustules 12 weeks- reduction of comedones, pustules, redness and decrease in recurrence of acne. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of acne scars, improvement of textureTimepoint: 4 weeks - improvement in erythema 8 weeks- improvement in texture 12 weeks- overall improvement in texture & acne scars | — |
Countries
India
Contacts
Public ContactDr Kallepu Rishika Sagar
S.R.M UNIVERSITY
Outcome results
None listed